Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$877M |
| 2 |
Booking.com
BKNG
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$329M |
| 4 |
Boeing
BA
|
+$303M |
| 5 |
Walmart Inc
WMT
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$544M |
| 2 |
iShares MBS ETF
MBB
|
+$461M |
| 3 |
NVIDIA
NVDA
|
+$452M |
| 4 |
T-Mobile US
TMUS
|
+$426M |
| 5 |
Apple
AAPL
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.15% |
| 2 | Healthcare | 3.06% |
| 3 | Financials | 2.35% |
| 4 | Consumer Discretionary | 2.28% |
| 5 | Industrials | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7401
PUT
Porch Group
PRCH
$1.9B
| $1.36M | ﹤0.01% |
70,600
-86,500
| -55% | -$1.43M |
|
7402
PUT
Ligand Pharmaceuticals
LGND
$5.73B
| $1.36M | ﹤0.01% |
16,671
-86,883
| -84% | -$7.23M |
|
7403
iShares MSCI Australia ETF
EWA
$1.42B
| $1.36M | ﹤0.01% |
52,464
-641,711
| -92% | -$16.9M |
|
7404
LiveOne
LVO
$53.9M
| $1.36M | ﹤0.01% |
28,879
+3,987
| +16% | +$173K |
|
|
SVM
7405
PUT
Silvercorp Metals
SVM
$2.55B
| $1.36M | ﹤0.01% |
248,200
-75,000
| -23% | -$435K |
|
7406
CALL
TTEC Holdings
TTEC
$71.5M
| $1.36M | ﹤0.01% |
13,200
-1,100
| -8% | -$114K |
|
7407
Four Corners Property Trust
FCPT
$2.75B
| $1.36M | ﹤0.01% |
49,254
-600,619
| -92% | -$17M |
|
7408
PUT
Direxion Daily Real Estate Bull 3X ETF
DRN
$45.8M
| $1.36M | ﹤0.01% |
63,300
-49,800
| -44% | -$985K |
|
7409
W.P. Carey
WPC
$16.3B
| $1.36M | ﹤0.01% |
18,591
-37,681
| -67% | -$2.76M |
|
7410
CALL
XP
XP
$8.18B
| $1.36M | ﹤0.01% |
31,200
-39,700
| -56% | -$1.64M |
|
|
FLG
7411
CALL
Flagstar Bank National Association
FLG
$5.81B
| $1.36M | ﹤0.01% |
41,100
-20,400
| -33% | -$730K |
|
7412
VanEck Biotech ETF
BBH
$437M
| $1.36M | ﹤0.01% |
6,733
-11,021
| -62% | -$2.05M |
|
7413
CALL
MillerKnoll
MLKN
$1.59B
| $1.36M | ﹤0.01% |
28,800
+11,300
| +65% | +$512K |
|
7414
CALL
Patrick Industries
PATK
$2.72B
| $1.36M | ﹤0.01% |
27,900
+22,500
| +417% | +$1.29M |
|
7415
PUT
Fidelity National Financial
FNF
$13.2B
| $1.36M | ﹤0.01% |
32,448
-4,680
| -13% | -$204K |
|
7416
McEwen Inc
MUX
$1.16B
| $1.36M | ﹤0.01% |
98,281
+51,205
| +109% | +$678K |
|
|
PRAH
7417
PUT
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.35M | ﹤0.01% |
8,200
-13,600
| -62% | -$2.27M |
|
7418
CALL
iShares MSCI USA Min Vol Factor ETF
USMV
$24.2B
| $1.35M | ﹤0.01% |
18,400
-3,800
| -17% | -$275K |
|
7419
PUT
Genuine Parts
GPC
$18.3B
| $1.35M | ﹤0.01% |
10,700
-3,000
| -22% | -$378K |
|
7420
Dianthus Therapeutics
DNTH
$6.42B
| $1.35M | ﹤0.01% |
8,642
-39,821
| -82% | -$7.31M |
|
|
RVNC
7421
CALL
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.35M | ﹤0.01% |
45,600
-6,100
| -12% | -$176K |
|
7422
PUT
Personalis
PSNL
$1.48B
| $1.35M | ﹤0.01% |
53,400
+6,000
| +13% | +$137K |
|
7423
PUT
Direxion Daily MSCI India Bull 2X ETF
INDL
$55.9M
| $1.35M | ﹤0.01% |
26,200
+19,100
| +269% | +$926K |
|
|
KNDI
7424
CALL
Kandi Technologies Group
KNDI
$63.3M
| $1.35M | ﹤0.01% |
225,500
-390,400
| -63% | -$2.23M |
|
7425
CALL
Lazard
LAZ
$4.26B
| $1.35M | ﹤0.01% |
29,800
-22,500
| -43% | -$1.03M |
|
Similar funds
Ken Griffin's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
- Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
- Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
- Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
- Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
- Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
- Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.